All Type of News
National Assembly passes bill over anti-rebate
The National Assembly on April 28 approved a bill to bring criminal charges against doctors and pharmacists who take rebates from drug makers when purchasing medicine.
After the six-month grace period, the regulati...
Doctors challenge anti-rebate bill
The National Assembly finally passed a bill to sanction doctors and pharmacists who are found to receive illegal rebates from drug makers, despite vehement oppositions from the medical sector.
However, the tug of w...
Drug makers, doctors at odds over bill against rebates
A dispute is brewing between pharmaceutical companies and doctors, after the National Assembly passed a bill to stop the practice of giving “illegal rebates'' here.
Last August the Ministry of Health and Welfare l...
Pharmaceutical colleges to run 6-year programs
The Ministry of Education, Science and Technology unveiled its plan to extend the duration of pharmaceutical programs from four to six years of study, if there is a consensus in the pharmaceutical circle.
In a sess...
Government to overhaul drug reclassification system
The government will push for a regulation change to allow the reclassification of medicinal products at all times, thus enabling consumers to have easy access to the drugs.
The Free Trade Commission will formulate ...
Assembly panel passes bill on sanctions of doctors and pharmacists
The Judiciary Committee of the National Assembly passed a bill on April 28 aimed at dual punishment on both the giving and receiving ends of illegal rebates.
The majority of 194 lawmakers voted for the legislation,...
Zuellig, Kyundongsa to set up JV
Zuellig Pharma Korea and Kyundongsa plan to establish a joint venture through their joint equity investment.
ZPK will provide distribution and logistics expertise to the joint venture on a contract basis, saying th...
Bioequivalence to become compulsory for generic combination drugs
From this October, generic combinations drugs produced cheaply in Korea must prove they are equivalent to the patented medicines on which they are modeled, the Korea Food and Drug Administration said on April 27.
T...
Pharmacists in Seoul calls for delay of drug pricing reform
The Seoul Pharmaceutical Chapter of the Korean Pharmaceutical Association (KPA) has urged the Ministry for Health, Welfare and Family Affairs to reconsider its plan to provide cash rewards to doctors and pharmacists w...
Yuyu enjoys robust sales of Yuclid
Yuyu Pharm has recently had its big smiles over the better-than-expected revenues of Yuclid tablets, of a combination of ticlopidine and ginkgo biloba extract.
The company said Yuclid achieved 2.6 billion won in sa...
